Abstract
Obesity is fast becoming a worldwide health concern and causes a chronic state of oxidative stress and low-grade inflammation, which could be major risk factors for a number of chronic diseases. We investigated the potential of the 61 probiotic candidates isolated from infant feces towards activity of lipid accumulation inhibition, and then we extended the study to evaluate their antidiabetic and antioxidant activity. Seven strains were finally selected based on their ability to inhibit lipid accumulation (>60%) and productivity yield (>1 × 1011 colony forming units [CFU]/g): Lactobacillus acidophilus MG4558; Lactobacillus paracasei MG4592; Lactobacillus plantarum MG4553 and MG4555; and Lactobacillus rhamnosus MG4502, MG4511, and MG4505. Selected strains showed high α-glucosidase-inhibiting activity (> 50%), except for MG4511 (19.8%), and similar antioxidant activities were reflected by the results of DPPH (21.6–27.5%) and ABTS (40.9–44.9%) assays. With respect to their functional properties as probiotics, most of the strains were resistant to simulated gastric (pH 3 and 4) and intestinal (pH 7 and 8) fluids, and possessed various probiotic-related factors, including autoaggregation ability, antibiotic susceptibility, enzyme production, and biochemical profiles, and were non-hemolytic. We conclude that our strains may be good probiotic candidates for functional food ingredients to prevent metabolic disorders such as obesity and diabetes.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Keunen, K., R. M. Van Elburg, F. Van Bel, and M. J. N. L. Benders (2015) Impact of nutrition on brain development and its neuroprotective implications following preterm birth. Pediatr. Res. 77: 148–155.
Goodrich, J. K., J. L. Waters, A. C. Poole, J. L. Sutter, O. Koren, R. Blekhman, M. Beaumont, W. Van Treuren, R. Knight, J. T. Bell, T. D. Spector, A. G. Clark, and R. E. Ley (2014) Human genetics shape the gut microbiome. Cell. 159: 789–799.
Cox, C. M. and R. A. Dalloul (2015) Immunomodulatory role of probiotics in poultry and potential in ovo application. Benef. Microbes. 6: 45–52.
Derrien, M., A. S. Alvarez, and W. M. de Vos (2019) The gut microbiota in the first decade of life. Trends. Microbiol. 27: 997–1010.
Nagpal, R., S. Wang, S. Ahmadi, J. Hayes, J. Gagliano, S. Subashchandrabose, D. W. Kitzman, T. Becton, R. Read, and H. Yadav (2018) Human-origin probiotic cocktail increases short-chain fatty acid production via modulation of mice and human gut microbiome. Sci. Rep. 8: 12649.
Plaza-Diaz, J., F. J. Ruiz-Ojeda, M. Gil-Campos, and A. Gil (2019) Mechanisms of action of probiotics. Adv. Nutr. 10: S49–S66.
Kadooka, Y., M. Sato, K. Imaizumi, A. Ogawa, K. Ikuyama, Y. Akai, M. Okano, M. Kagoshima, and T. Tsuchida (2010) Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. Eur. J. Clin. Nutr. 64: 636–643.
Sato, M., K. Uzu, T. Yoshida, E. M. Hamad, H. Kawakami, H. Matsuyama, I. A. Abd El-Gawad, and K. Imaizumi (2008) Effects of milk fermented by Lactobacillus gasseri SBT2055 on adipocyte size in rats. Br. J. Nutr. 99: 1013–1017.
Ma, X., J. Hua, and Z. Li (2008) Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells. J. Hepatol. 49: 821–830.
Choi, W. J., H. J. Dong, H. U. Jeong, D. W. Ryu, S. M. Song, Y. R. Kim, H. H. Jung, T. H. Kim, and Y. H. Kim (2020) Lactobacillus plantarum LMT1-48 exerts anti-obesity effect in high-fat diet-induced obese mice by regulating expression of lipogenic genes. Sci. Rep. 10: 869.
Holmes, E., J. V. Li, J. R. Marchesi, and J. K. Nicholson (2012) Gut microbiota composition and activity in relation to host metabolic phenotype and disease risk. Cell Metab. 16: 559–564.
Ouwehand, A. C., S. Salminen, and E. Isolauri (2002) Probiotics: an overview of beneficial effects. Proceedings of the 7th Symposium on Lactic Acid Bacteria: Genetics, Metabolism and Applications. September 1–5. Egmond aan Zee, Netherlands.
Lee, J., A. R. Kim, and J. J. Lee (2016) Ramie leaf extracts suppresses adipogenic differentiation in 3T3-L1 cells and pig preadipocytes. Asian-Australas. J. Anim. Sci. 29: 1338–1344.
Rizzatti, V., F. Boschi, M. Pedrotti, E. Zoico, A. Sbarbati, and M. Zamboni (2013) Lipid droplets characterization in adipocyte differentiated 3T3-L1 cells: size and optical density distribution. Eur. J. Histochem. 57: e24.
Chen, P., Q. Zhang, H. Dang, X. Liu, F. Tian, J. Zhao, Y. Chen, H. Zhang, and W. Chen (2014) Screening for potential new probiotic based on probiotic properties and α-glucosidase inhibitory activity. Food Control. 35: 65–72.
Blois, M. S. (1958) Antioxidant determinations by the use of a stable free radical. Nature. 181: 1199–1200.
Re, R., N. Pellegrini, A. Proteggente, A. Pannala, M. Yang, and C. Rice-Evans (1999) Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic. Biol. Med. 26: 1231–1237.
Maragkoudakis, P. A., G. Zoumpopoulou, C. Miaris, G. Kalantzopoulos, B. Pot, and E. Tsakalidou (2006) Probiotic potential of Lactobacillus strains isolated from dairy products. Int. Dairy J. 16: 189–199.
Kos, B., J. Šušković, S. Vuković, M. Šimpraga, J. Frece, and S. Matošić (2003) Adhesion and aggregation ability of probiotic strain Lactobacillus acidophilus M92. J. Appl. Microbiol. 94: 981–987.
EFSA (2012) Guidance on the assessment of bacterial susceptibility to antimicrobials of human and veterinary importance. EFSA J. 10: 2740.
Frank, D. N., W. Zhu, R. B. Sartor, and E. Li (2011) Investigating the biological and clinical significance of human dysbioses. Trends Microbiol. 19: 427–434.
Cani, P. D. and N. M. Delzenne (2009) Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota. Curr. Opin. Pharmacol. 9: 737–743.
Larsen, N., F. K. Vogensen, F. W. J. van den Berg, D. S. Nielsen, A. S. Andreasen, B. K. Pedersen, W. A. Al-Soud, S. J. Sørensen, L. H. Hansen, and M. Jakobsen (2010) Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One. 5: e9085.
Pflughoeft, K. J. and J. Versalovic (2012) Human microbiome in health and disease. Annu. Rev. Pathol. 7: 99–122.
Park, D. Y., Y. T. Ahn, S. H. Park, C. S. Huh, S. R. Yoo, R. Yu, M. K. Sung, R. A. McGregor, and M. S. Choi (2013) Supplementation of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 in diet-induced obese mice is associated with gut microbial changes and reduction in obesity. PLoS One. 8: e59470.
Kim, S., E. Huang, S. Park, W. Holzapfel, and S. D. Lim (2018) Physiological characteristics and anti-obesity effect of Lactobacillus plantarum K10. Korean J. Food Sci. Anim. Resour. 38: 554–569.
Zhang, Y., L. Wang, J. Zhang, Y. Li, Q. He, H. Li, X. Guo, J. Guo, and H. Zhang (2014) Probiotic Lactobacillus casei Zhang ameliorates high-fructose-induced impaired glucose tolerance in hyperinsulinemia rats. Eur. J. Nutr. 53: 221–232.
Marazza, J. A., J. G. LeBlanc, G S. de Giori, and M. S. Garro (2013) Soymilk fermented with Lactobacillus rhamnosus CRL981 ameliorates hyperglycemia, lipid profiles and increases antioxidant enzyme activities in diabetic mice. J. Funct. Foods. 5: 1848–1853.
Yadav, H., J. H. Lee, J. Lloyd, P. Walter, and S. G. Rane (2013) Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion. J. Biol. Chem. 288: 25088–25097.
Schaich, K. M., X. Tian, and J. Xie (2015) Hurdles and pitfalls in measuring antioxidant efficacy: A critical evaluation of ABTS, DPPH, and ORAC assays. J. Funct. Foods. 14: 111–125.
Li, S., Y. Zhao, L. Zhang, X. Zhang, L. Huang, D. Li, C. Niu, Z. Yang, and Q. Wang (2012) Antioxidant activity of Lactobacillus plantarum strains isolated from traditional Chinese fermented foods. Food Chem. 135: 1914–1919.
Afify, A. E. M. M., R. M. Romeilah, S. I. M. Sultan, and M. M. Hussein (2012) Antioxidant activity and biological evaluations of probiotic bacteria strains. Int. J. Acad. Res. 4: 131–139.
Rajoka, M. S. R., H. M. Mehwish, M. Siddiq, Z. Haobin, J. Zhu, L. Yan, D. Shao, X. Xu, and J. Shi (2017) Identification, characterization, and probiotic potential of Lactobacillus rhamnosus isolated from human milk. LWT. 84: 271–280.
Angelin, J. and M. Kavitha (2020) Exopolysaccharides from probiotic bacteria and their health potential. Int. J. Biol. Macromol. 162: 853–865.
Kodali V. P. and R. Sen (2008) Antioxidant and free radical scavenging activities of an exopolysaccharide from a probiotic bacterium. Biotechnol. J. 3: 245–251.
Pan, D. and X. Mei (2010) Antioxidant activity of an exopolysaccharide purified from Lactococcus lactis subsp. lactis 12. Carbohydr. Polym. 80: 908–914.
Ruas-Madiedo, P. and C. G. de los Reyes-Gavilán (2005) Invited review: methods for the screening, isolation, and characterization of exopolysaccharides produced by lactic acid bacteria. J. Dairy Sci. 88: 843–856.
Sanalibaba, P. and G. A. Çakmak (2016) Exopolysaccharides production by lactic acid bacteria. Appl. Microbiol. Open Access. 2: 1000115.
Charteris, W. P., P. M. Kelly, L. Morelli, and J. K. Collins (2001) Gradient diffusion antibiotic susceptibility testing of potentially probiotic lactobacilli. J. Food Prot. 64: 2007–2014.
Acknowledgments
This work was supported by MEDIOGEN Co., Ltd. (Korea). No other funding was received for this project.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Conflict of Interest
The authors declare that they have no conflict of interest.
Ethical Statement
Neither ethical approval nor informed consent was required for this study.
Rights and permissions
About this article
Cite this article
Kim, H., Jeong, Y., Kim, JE. et al. Anti-obesity Potential of Lactobacillus spp. Isolated from Infant Feces. Biotechnol Bioproc E 26, 575–585 (2021). https://doi.org/10.1007/s12257-020-0309-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12257-020-0309-x